Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW, Lee TY, Johannson KA, Assayag D, Morisset J, Fell CD, Fisher JH, Shapera S, Gershon AS, Cox G, Halayko AJ, Hambly N, Manganas H, Sadatsafavi M, Wilcox PG, To T, Marcoux V, Khalil N, Kolb M, Ryerson CJ. Wong AW, et al. Among authors: marcoux v. Respir Res. 2020 Dec 7;21(1):322. doi: 10.1186/s12931-020-01579-7. Respir Res. 2020. PMID: 33287805 Free PMC article.
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung Disease.
Johannson KA, Lethebe BC, Assayag D, Fisher JH, Kolb M, Morisset J, Shapera S, Gershon AS, Hambly N, Khalil N, To T, Fell CD, Cox G, Manganas H, Halayko AJ, Marcoux V, Sadatsafavi M, Wilcox PG, Bertazzon S, Ryerson CJ. Johannson KA, et al. Among authors: marcoux v. Ann Am Thorac Soc. 2022 Jan;19(1):20-27. doi: 10.1513/AnnalsATS.202102-216OC. Ann Am Thorac Soc. 2022. PMID: 34033739
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.
Goobie GC, Ryerson CJ, Johannson KA, Schikowski E, Zou RH, Khalil N, Marcoux V, Assayag D, Manganas H, Fisher JH, Kolb MRJ, Gibson KF, Kass DJ, Zhang Y, Lindell KO, Nouraie SM. Goobie GC, et al. Among authors: marcoux v. Am J Respir Crit Care Med. 2022 Feb 15;205(4):459-467. doi: 10.1164/rccm.202109-2065OC. Am J Respir Crit Care Med. 2022. PMID: 34818133
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease.
Wong AW, Khor YH, Donohoe K, Comes A, Marcoux V, Fisher JH, Johannson KA, Assayag D, Morisset J, Shapera S, Khalil N, Fell CD, Manganas H, Cox G, To T, Gershon AS, Hambly N, Halayko AJ, Sadatsafavi M, Wilcox PG, Kolb M, Richeldi L, Ryerson CJ. Wong AW, et al. Among authors: marcoux v. Ann Am Thorac Soc. 2022 May;19(5):863-867. doi: 10.1513/AnnalsATS.202108-954RL. Ann Am Thorac Soc. 2022. PMID: 34898386 No abstract available.
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study.
Adams CJ, Shapera S, Ryerson CJ, Assayag D, Johannson KA, Fell CD, Morisset J, Manganas H, Kolb M, Hambly N, Cox G, Khalil N, Marcoux V, Wilcox PG, To T, Sadatsafavi M, Halayko AJ, Gershon A, Garlick K, Fisher JH. Adams CJ, et al. Among authors: marcoux v. Respir Med. 2022 Jan;191:106722. doi: 10.1016/j.rmed.2021.106722. Epub 2021 Dec 23. Respir Med. 2022. PMID: 34959146 Free article.
50 results